4 Results for "

RTH

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "RTH" in MCE Product Catalog:

Cat. No.: HY-P9973
CAS No.: 1531589-13-5
Synonyms: DLX1008; ESBA 1008; RTH258

Target:  

VEGFR

Research Areas:  

Cancer

Brolucizumab (DLX1008) is a single-chain anti-VEGF-A antibody fragment with low picomolar affinity (KD=1.05 pM). Brolucizumab can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-P10221A
Research Areas:  

Cancer

Cyclo(CKLIIF) TFA is an inhibitor of HIF-1α and HIF-2α. The KD values of Cyclo(CKLIIF) TFA for the PAS-B domains of HIF1-α and HIF2-α are 2.6 μM and 2.2 μM, respectively. Cyclo(CKLIIF) TFA disrupts the protein-protein interaction between HIF-1α and HIF-1β. Cyclo(CKLIIF) TFA can be used in cancer research .
loading...
    loading...
Cat. No.: HY-146997
CAS No.: 2770681-85-9
Research Areas:  

Metabolic Disease

TRβ agonist 1 is a selective and mutation-sensitive thyroid hormone receptor β (TRβ) agonist, with an EC50 value of 21 nM. TRβ agonist 1 can be used for researching dyslipidemia, nonalcoholic steatohepatitis (NASH), and resistance to thyroid hormone (RTH) .
loading...
    loading...
Cat. No.: HY-174887
CAS No.: 2920045-74-3
THR-β agonist 9 is a potent, selective, and His435 mutation-sensitive THR-β (EC50: 3.2 nM) agonist. THR-β agonist 9 has moderate selectivity (approximately 10-fold) and good activation capacity (EC50: 134.2 nM to 515.5 nM) for multiple His435 mutants (H435A, H435Y, and H435R). THR-β agonist 9 has the potential to be used in the study of dyslipidemia, metabolic dysfunction-associated steatohepatitis (MASH), or resistance to thyroid hormone (RTH) .
loading...
    loading...